Global Non-Invasive Glucose Monitoring Market Growth 2024-2030

February 2024 | 115 pages | ID: G899F4FC0221EN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

According to our LPI (LP Information) latest study, the global Non-Invasive Glucose Monitoring market size was valued at US$ 4986.4 million in 2023. With growing demand in downstream market, the Non-Invasive Glucose Monitoring is forecast to a readjusted size of US$ 6311.3 million by 2030 with a CAGR of 3.4% during review period.

The research report highlights the growth potential of the global Non-Invasive Glucose Monitoring market. Non-Invasive Glucose Monitoring are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Non-Invasive Glucose Monitoring. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Non-Invasive Glucose Monitoring market.

Non-invasive glucose monitoring refers to blood glucose measurement methods that do not require the collection of a blood sample. These methods include technologies such as optical sensors, spectroscopy, and transdermal glucose monitoring.

The market for non-invasive glucose monitoring is driven by the growing demand for painless and convenient glucose monitoring solutions, especially among individuals with diabetes who require frequent blood glucose testing. Technological advancements in non-invasive glucose monitoring devices, such as wearable sensors and mobile health applications, have also impacted the market's growth.

Key Features:

The report on Non-Invasive Glucose Monitoring market reflects various aspects and provide valuable insights into the industry.

Market Size and Growth: The research report provide an overview of the current size and growth of the Non-Invasive Glucose Monitoring market. It may include historical data, market segmentation by Type (e.g., Wearable Blood Glucose Monitoring Systems, Table Top Blood Glucose Monitoring Systems), and regional breakdowns.

Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Non-Invasive Glucose Monitoring market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.

Competitive Landscape: The research report provides analysis of the competitive landscape within the Non-Invasive Glucose Monitoring market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.

Technological Developments: The research report can delve into the latest technological developments in the Non-Invasive Glucose Monitoring industry. This include advancements in Non-Invasive Glucose Monitoring technology, Non-Invasive Glucose Monitoring new entrants, Non-Invasive Glucose Monitoring new investment, and other innovations that are shaping the future of Non-Invasive Glucose Monitoring.

Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Non-Invasive Glucose Monitoring market. It includes factors influencing customer ' purchasing decisions, preferences for Non-Invasive Glucose Monitoring product.

Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Non-Invasive Glucose Monitoring market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Non-Invasive Glucose Monitoring market. The report also evaluates the effectiveness of these policies in driving market growth.

Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Non-Invasive Glucose Monitoring market.

Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Non-Invasive Glucose Monitoring industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.

Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Non-Invasive Glucose Monitoring market.

Market Segmentation:

Non-Invasive Glucose Monitoring market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.

Segmentation by type
  • Wearable Blood Glucose Monitoring Systems
  • Table Top Blood Glucose Monitoring Systems
Segmentation by application
  • Hospitals
  • Clinics
  • Others
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
  • Abbott
  • Medtronic
  • Roche
  • Bayer AG
  • B. Braun
  • Nipro Diagnostics
  • Life Scan Inc.(J&J)
  • Arkray Devices
  • Nova Biomedical
  • Bionime Corporation
  • Sinocare
  • Hybio Pharmaceutical
  • Lepu Medical
  • Yuyue Medical
Key Questions Addressed in this Report

What is the 10-year outlook for the global Non-Invasive Glucose Monitoring market?

What factors are driving Non-Invasive Glucose Monitoring market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Non-Invasive Glucose Monitoring market opportunities vary by end market size?

How does Non-Invasive Glucose Monitoring break out type, application?
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Non-Invasive Glucose Monitoring Annual Sales 2019-2030
  2.1.2 World Current & Future Analysis for Non-Invasive Glucose Monitoring by Geographic Region, 2019, 2023 & 2030
  2.1.3 World Current & Future Analysis for Non-Invasive Glucose Monitoring by Country/Region, 2019, 2023 & 2030
2.2 Non-Invasive Glucose Monitoring Segment by Type
  2.2.1 Wearable Blood Glucose Monitoring Systems
  2.2.2 Table Top Blood Glucose Monitoring Systems
2.3 Non-Invasive Glucose Monitoring Sales by Type
  2.3.1 Global Non-Invasive Glucose Monitoring Sales Market Share by Type (2019-2024)
  2.3.2 Global Non-Invasive Glucose Monitoring Revenue and Market Share by Type (2019-2024)
  2.3.3 Global Non-Invasive Glucose Monitoring Sale Price by Type (2019-2024)
2.4 Non-Invasive Glucose Monitoring Segment by Application
  2.4.1 Hospitals
  2.4.2 Clinics
  2.4.3 Others
2.5 Non-Invasive Glucose Monitoring Sales by Application
  2.5.1 Global Non-Invasive Glucose Monitoring Sale Market Share by Application (2019-2024)
  2.5.2 Global Non-Invasive Glucose Monitoring Revenue and Market Share by Application (2019-2024)
  2.5.3 Global Non-Invasive Glucose Monitoring Sale Price by Application (2019-2024)

3 GLOBAL NON-INVASIVE GLUCOSE MONITORING BY COMPANY

3.1 Global Non-Invasive Glucose Monitoring Breakdown Data by Company
  3.1.1 Global Non-Invasive Glucose Monitoring Annual Sales by Company (2019-2024)
  3.1.2 Global Non-Invasive Glucose Monitoring Sales Market Share by Company (2019-2024)
3.2 Global Non-Invasive Glucose Monitoring Annual Revenue by Company (2019-2024)
  3.2.1 Global Non-Invasive Glucose Monitoring Revenue by Company (2019-2024)
  3.2.2 Global Non-Invasive Glucose Monitoring Revenue Market Share by Company (2019-2024)
3.3 Global Non-Invasive Glucose Monitoring Sale Price by Company
3.4 Key Manufacturers Non-Invasive Glucose Monitoring Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Non-Invasive Glucose Monitoring Product Location Distribution
  3.4.2 Players Non-Invasive Glucose Monitoring Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 WORLD HISTORIC REVIEW FOR NON-INVASIVE GLUCOSE MONITORING BY GEOGRAPHIC REGION

4.1 World Historic Non-Invasive Glucose Monitoring Market Size by Geographic Region (2019-2024)
  4.1.1 Global Non-Invasive Glucose Monitoring Annual Sales by Geographic Region (2019-2024)
  4.1.2 Global Non-Invasive Glucose Monitoring Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Non-Invasive Glucose Monitoring Market Size by Country/Region (2019-2024)
  4.2.1 Global Non-Invasive Glucose Monitoring Annual Sales by Country/Region (2019-2024)
  4.2.2 Global Non-Invasive Glucose Monitoring Annual Revenue by Country/Region (2019-2024)
4.3 Americas Non-Invasive Glucose Monitoring Sales Growth
4.4 APAC Non-Invasive Glucose Monitoring Sales Growth
4.5 Europe Non-Invasive Glucose Monitoring Sales Growth
4.6 Middle East & Africa Non-Invasive Glucose Monitoring Sales Growth

5 AMERICAS

5.1 Americas Non-Invasive Glucose Monitoring Sales by Country
  5.1.1 Americas Non-Invasive Glucose Monitoring Sales by Country (2019-2024)
  5.1.2 Americas Non-Invasive Glucose Monitoring Revenue by Country (2019-2024)
5.2 Americas Non-Invasive Glucose Monitoring Sales by Type
5.3 Americas Non-Invasive Glucose Monitoring Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Non-Invasive Glucose Monitoring Sales by Region
  6.1.1 APAC Non-Invasive Glucose Monitoring Sales by Region (2019-2024)
  6.1.2 APAC Non-Invasive Glucose Monitoring Revenue by Region (2019-2024)
6.2 APAC Non-Invasive Glucose Monitoring Sales by Type
6.3 APAC Non-Invasive Glucose Monitoring Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Non-Invasive Glucose Monitoring by Country
  7.1.1 Europe Non-Invasive Glucose Monitoring Sales by Country (2019-2024)
  7.1.2 Europe Non-Invasive Glucose Monitoring Revenue by Country (2019-2024)
7.2 Europe Non-Invasive Glucose Monitoring Sales by Type
7.3 Europe Non-Invasive Glucose Monitoring Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Non-Invasive Glucose Monitoring by Country
  8.1.1 Middle East & Africa Non-Invasive Glucose Monitoring Sales by Country (2019-2024)
  8.1.2 Middle East & Africa Non-Invasive Glucose Monitoring Revenue by Country (2019-2024)
8.2 Middle East & Africa Non-Invasive Glucose Monitoring Sales by Type
8.3 Middle East & Africa Non-Invasive Glucose Monitoring Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Non-Invasive Glucose Monitoring
10.3 Manufacturing Process Analysis of Non-Invasive Glucose Monitoring
10.4 Industry Chain Structure of Non-Invasive Glucose Monitoring

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Non-Invasive Glucose Monitoring Distributors
11.3 Non-Invasive Glucose Monitoring Customer

12 WORLD FORECAST REVIEW FOR NON-INVASIVE GLUCOSE MONITORING BY GEOGRAPHIC REGION

12.1 Global Non-Invasive Glucose Monitoring Market Size Forecast by Region
  12.1.1 Global Non-Invasive Glucose Monitoring Forecast by Region (2025-2030)
  12.1.2 Global Non-Invasive Glucose Monitoring Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Non-Invasive Glucose Monitoring Forecast by Type
12.7 Global Non-Invasive Glucose Monitoring Forecast by Application

13 KEY PLAYERS ANALYSIS

13.1 Abbott
  13.1.1 Abbott Company Information
  13.1.2 Abbott Non-Invasive Glucose Monitoring Product Portfolios and Specifications
  13.1.3 Abbott Non-Invasive Glucose Monitoring Sales, Revenue, Price and Gross Margin (2019-2024)
  13.1.4 Abbott Main Business Overview
  13.1.5 Abbott Latest Developments
13.2 Medtronic
  13.2.1 Medtronic Company Information
  13.2.2 Medtronic Non-Invasive Glucose Monitoring Product Portfolios and Specifications
  13.2.3 Medtronic Non-Invasive Glucose Monitoring Sales, Revenue, Price and Gross Margin (2019-2024)
  13.2.4 Medtronic Main Business Overview
  13.2.5 Medtronic Latest Developments
13.3 Roche
  13.3.1 Roche Company Information
  13.3.2 Roche Non-Invasive Glucose Monitoring Product Portfolios and Specifications
  13.3.3 Roche Non-Invasive Glucose Monitoring Sales, Revenue, Price and Gross Margin (2019-2024)
  13.3.4 Roche Main Business Overview
  13.3.5 Roche Latest Developments
13.4 Bayer AG
  13.4.1 Bayer AG Company Information
  13.4.2 Bayer AG Non-Invasive Glucose Monitoring Product Portfolios and Specifications
  13.4.3 Bayer AG Non-Invasive Glucose Monitoring Sales, Revenue, Price and Gross Margin (2019-2024)
  13.4.4 Bayer AG Main Business Overview
  13.4.5 Bayer AG Latest Developments
13.5 B. Braun
  13.5.1 B. Braun Company Information
  13.5.2 B. Braun Non-Invasive Glucose Monitoring Product Portfolios and Specifications
  13.5.3 B. Braun Non-Invasive Glucose Monitoring Sales, Revenue, Price and Gross Margin (2019-2024)
  13.5.4 B. Braun Main Business Overview
  13.5.5 B. Braun Latest Developments
13.6 Nipro Diagnostics
  13.6.1 Nipro Diagnostics Company Information
  13.6.2 Nipro Diagnostics Non-Invasive Glucose Monitoring Product Portfolios and Specifications
  13.6.3 Nipro Diagnostics Non-Invasive Glucose Monitoring Sales, Revenue, Price and Gross Margin (2019-2024)
  13.6.4 Nipro Diagnostics Main Business Overview
  13.6.5 Nipro Diagnostics Latest Developments
13.7 Life Scan Inc.(J&J)
  13.7.1 Life Scan Inc.(J&J) Company Information
  13.7.2 Life Scan Inc.(J&J) Non-Invasive Glucose Monitoring Product Portfolios and Specifications
  13.7.3 Life Scan Inc.(J&J) Non-Invasive Glucose Monitoring Sales, Revenue, Price and Gross Margin (2019-2024)
  13.7.4 Life Scan Inc.(J&J) Main Business Overview
  13.7.5 Life Scan Inc.(J&J) Latest Developments
13.8 Arkray Devices
  13.8.1 Arkray Devices Company Information
  13.8.2 Arkray Devices Non-Invasive Glucose Monitoring Product Portfolios and Specifications
  13.8.3 Arkray Devices Non-Invasive Glucose Monitoring Sales, Revenue, Price and Gross Margin (2019-2024)
  13.8.4 Arkray Devices Main Business Overview
  13.8.5 Arkray Devices Latest Developments
13.9 Nova Biomedical
  13.9.1 Nova Biomedical Company Information
  13.9.2 Nova Biomedical Non-Invasive Glucose Monitoring Product Portfolios and Specifications
  13.9.3 Nova Biomedical Non-Invasive Glucose Monitoring Sales, Revenue, Price and Gross Margin (2019-2024)
  13.9.4 Nova Biomedical Main Business Overview
  13.9.5 Nova Biomedical Latest Developments
13.10 Bionime Corporation
  13.10.1 Bionime Corporation Company Information
  13.10.2 Bionime Corporation Non-Invasive Glucose Monitoring Product Portfolios and Specifications
  13.10.3 Bionime Corporation Non-Invasive Glucose Monitoring Sales, Revenue, Price and Gross Margin (2019-2024)
  13.10.4 Bionime Corporation Main Business Overview
  13.10.5 Bionime Corporation Latest Developments
13.11 Sinocare
  13.11.1 Sinocare Company Information
  13.11.2 Sinocare Non-Invasive Glucose Monitoring Product Portfolios and Specifications
  13.11.3 Sinocare Non-Invasive Glucose Monitoring Sales, Revenue, Price and Gross Margin (2019-2024)
  13.11.4 Sinocare Main Business Overview
  13.11.5 Sinocare Latest Developments
13.12 Hybio Pharmaceutical
  13.12.1 Hybio Pharmaceutical Company Information
  13.12.2 Hybio Pharmaceutical Non-Invasive Glucose Monitoring Product Portfolios and Specifications
  13.12.3 Hybio Pharmaceutical Non-Invasive Glucose Monitoring Sales, Revenue, Price and Gross Margin (2019-2024)
  13.12.4 Hybio Pharmaceutical Main Business Overview
  13.12.5 Hybio Pharmaceutical Latest Developments
13.13 Lepu Medical
  13.13.1 Lepu Medical Company Information
  13.13.2 Lepu Medical Non-Invasive Glucose Monitoring Product Portfolios and Specifications
  13.13.3 Lepu Medical Non-Invasive Glucose Monitoring Sales, Revenue, Price and Gross Margin (2019-2024)
  13.13.4 Lepu Medical Main Business Overview
  13.13.5 Lepu Medical Latest Developments
13.14 Yuyue Medical
  13.14.1 Yuyue Medical Company Information
  13.14.2 Yuyue Medical Non-Invasive Glucose Monitoring Product Portfolios and Specifications
  13.14.3 Yuyue Medical Non-Invasive Glucose Monitoring Sales, Revenue, Price and Gross Margin (2019-2024)
  13.14.4 Yuyue Medical Main Business Overview
  13.14.5 Yuyue Medical Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION


LIST OF TABLES

Table 1. Non-Invasive Glucose Monitoring Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Non-Invasive Glucose Monitoring Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Wearable Blood Glucose Monitoring Systems
Table 4. Major Players of Table Top Blood Glucose Monitoring Systems
Table 5. Global Non-Invasive Glucose Monitoring Sales by Type (2019-2024) & (K Units)
Table 6. Global Non-Invasive Glucose Monitoring Sales Market Share by Type (2019-2024)
Table 7. Global Non-Invasive Glucose Monitoring Revenue by Type (2019-2024) & ($ million)
Table 8. Global Non-Invasive Glucose Monitoring Revenue Market Share by Type (2019-2024)
Table 9. Global Non-Invasive Glucose Monitoring Sale Price by Type (2019-2024) & (US$/Unit)
Table 10. Global Non-Invasive Glucose Monitoring Sales by Application (2019-2024) & (K Units)
Table 11. Global Non-Invasive Glucose Monitoring Sales Market Share by Application (2019-2024)
Table 12. Global Non-Invasive Glucose Monitoring Revenue by Application (2019-2024)
Table 13. Global Non-Invasive Glucose Monitoring Revenue Market Share by Application (2019-2024)
Table 14. Global Non-Invasive Glucose Monitoring Sale Price by Application (2019-2024) & (US$/Unit)
Table 15. Global Non-Invasive Glucose Monitoring Sales by Company (2019-2024) & (K Units)
Table 16. Global Non-Invasive Glucose Monitoring Sales Market Share by Company (2019-2024)
Table 17. Global Non-Invasive Glucose Monitoring Revenue by Company (2019-2024) ($ Millions)
Table 18. Global Non-Invasive Glucose Monitoring Revenue Market Share by Company (2019-2024)
Table 19. Global Non-Invasive Glucose Monitoring Sale Price by Company (2019-2024) & (US$/Unit)
Table 20. Key Manufacturers Non-Invasive Glucose Monitoring Producing Area Distribution and Sales Area
Table 21. Players Non-Invasive Glucose Monitoring Products Offered
Table 22. Non-Invasive Glucose Monitoring Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Non-Invasive Glucose Monitoring Sales by Geographic Region (2019-2024) & (K Units)
Table 26. Global Non-Invasive Glucose Monitoring Sales Market Share Geographic Region (2019-2024)
Table 27. Global Non-Invasive Glucose Monitoring Revenue by Geographic Region (2019-2024) & ($ millions)
Table 28. Global Non-Invasive Glucose Monitoring Revenue Market Share by Geographic Region (2019-2024)
Table 29. Global Non-Invasive Glucose Monitoring Sales by Country/Region (2019-2024) & (K Units)
Table 30. Global Non-Invasive Glucose Monitoring Sales Market Share by Country/Region (2019-2024)
Table 31. Global Non-Invasive Glucose Monitoring Revenue by Country/Region (2019-2024) & ($ millions)
Table 32. Global Non-Invasive Glucose Monitoring Revenue Market Share by Country/Region (2019-2024)
Table 33. Americas Non-Invasive Glucose Monitoring Sales by Country (2019-2024) & (K Units)
Table 34. Americas Non-Invasive Glucose Monitoring Sales Market Share by Country (2019-2024)
Table 35. Americas Non-Invasive Glucose Monitoring Revenue by Country (2019-2024) & ($ Millions)
Table 36. Americas Non-Invasive Glucose Monitoring Revenue Market Share by Country (2019-2024)
Table 37. Americas Non-Invasive Glucose Monitoring Sales by Type (2019-2024) & (K Units)
Table 38. Americas Non-Invasive Glucose Monitoring Sales by Application (2019-2024) & (K Units)
Table 39. APAC Non-Invasive Glucose Monitoring Sales by Region (2019-2024) & (K Units)
Table 40. APAC Non-Invasive Glucose Monitoring Sales Market Share by Region (2019-2024)
Table 41. APAC Non-Invasive Glucose Monitoring Revenue by Region (2019-2024) & ($ Millions)
Table 42. APAC Non-Invasive Glucose Monitoring Revenue Market Share by Region (2019-2024)
Table 43. APAC Non-Invasive Glucose Monitoring Sales by Type (2019-2024) & (K Units)
Table 44. APAC Non-Invasive Glucose Monitoring Sales by Application (2019-2024) & (K Units)
Table 45. Europe Non-Invasive Glucose Monitoring Sales by Country (2019-2024) & (K Units)
Table 46. Europe Non-Invasive Glucose Monitoring Sales Market Share by Country (2019-2024)
Table 47. Europe Non-Invasive Glucose Monitoring Revenue by Country (2019-2024) & ($ Millions)
Table 48. Europe Non-Invasive Glucose Monitoring Revenue Market Share by Country (2019-2024)
Table 49. Europe Non-Invasive Glucose Monitoring Sales by Type (2019-2024) & (K Units)
Table 50. Europe Non-Invasive Glucose Monitoring Sales by Application (2019-2024) & (K Units)
Table 51. Middle East & Africa Non-Invasive Glucose Monitoring Sales by Country (2019-2024) & (K Units)
Table 52. Middle East & Africa Non-Invasive Glucose Monitoring Sales Market Share by Country (2019-2024)
Table 53. Middle East & Africa Non-Invasive Glucose Monitoring Revenue by Country (2019-2024) & ($ Millions)
Table 54. Middle East & Africa Non-Invasive Glucose Monitoring Revenue Market Share by Country (2019-2024)
Table 55. Middle East & Africa Non-Invasive Glucose Monitoring Sales by Type (2019-2024) & (K Units)
Table 56. Middle East & Africa Non-Invasive Glucose Monitoring Sales by Application (2019-2024) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Non-Invasive Glucose Monitoring
Table 58. Key Market Challenges & Risks of Non-Invasive Glucose Monitoring
Table 59. Key Industry Trends of Non-Invasive Glucose Monitoring
Table 60. Non-Invasive Glucose Monitoring Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Non-Invasive Glucose Monitoring Distributors List
Table 63. Non-Invasive Glucose Monitoring Customer List
Table 64. Global Non-Invasive Glucose Monitoring Sales Forecast by Region (2025-2030) & (K Units)
Table 65. Global Non-Invasive Glucose Monitoring Revenue Forecast by Region (2025-2030) & ($ millions)
Table 66. Americas Non-Invasive Glucose Monitoring Sales Forecast by Country (2025-2030) & (K Units)
Table 67. Americas Non-Invasive Glucose Monitoring Revenue Forecast by Country (2025-2030) & ($ millions)
Table 68. APAC Non-Invasive Glucose Monitoring Sales Forecast by Region (2025-2030) & (K Units)
Table 69. APAC Non-Invasive Glucose Monitoring Revenue Forecast by Region (2025-2030) & ($ millions)
Table 70. Europe Non-Invasive Glucose Monitoring Sales Forecast by Country (2025-2030) & (K Units)
Table 71. Europe Non-Invasive Glucose Monitoring Revenue Forecast by Country (2025-2030) & ($ millions)
Table 72. Middle East & Africa Non-Invasive Glucose Monitoring Sales Forecast by Country (2025-2030) & (K Units)
Table 73. Middle East & Africa Non-Invasive Glucose Monitoring Revenue Forecast by Country (2025-2030) & ($ millions)
Table 74. Global Non-Invasive Glucose Monitoring Sales Forecast by Type (2025-2030) & (K Units)
Table 75. Global Non-Invasive Glucose Monitoring Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 76. Global Non-Invasive Glucose Monitoring Sales Forecast by Application (2025-2030) & (K Units)
Table 77. Global Non-Invasive Glucose Monitoring Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 78. Abbott Basic Information, Non-Invasive Glucose Monitoring Manufacturing Base, Sales Area and Its Competitors
Table 79. Abbott Non-Invasive Glucose Monitoring Product Portfolios and Specifications
Table 80. Abbott Non-Invasive Glucose Monitoring Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 81. Abbott Main Business
Table 82. Abbott Latest Developments
Table 83. Medtronic Basic Information, Non-Invasive Glucose Monitoring Manufacturing Base, Sales Area and Its Competitors
Table 84. Medtronic Non-Invasive Glucose Monitoring Product Portfolios and Specifications
Table 85. Medtronic Non-Invasive Glucose Monitoring Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 86. Medtronic Main Business
Table 87. Medtronic Latest Developments
Table 88. Roche Basic Information, Non-Invasive Glucose Monitoring Manufacturing Base, Sales Area and Its Competitors
Table 89. Roche Non-Invasive Glucose Monitoring Product Portfolios and Specifications
Table 90. Roche Non-Invasive Glucose Monitoring Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 91. Roche Main Business
Table 92. Roche Latest Developments
Table 93. Bayer AG Basic Information, Non-Invasive Glucose Monitoring Manufacturing Base, Sales Area and Its Competitors
Table 94. Bayer AG Non-Invasive Glucose Monitoring Product Portfolios and Specifications
Table 95. Bayer AG Non-Invasive Glucose Monitoring Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 96. Bayer AG Main Business
Table 97. Bayer AG Latest Developments
Table 98. B. Braun Basic Information, Non-Invasive Glucose Monitoring Manufacturing Base, Sales Area and Its Competitors
Table 99. B. Braun Non-Invasive Glucose Monitoring Product Portfolios and Specifications
Table 100. B. Braun Non-Invasive Glucose Monitoring Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 101. B. Braun Main Business
Table 102. B. Braun Latest Developments
Table 103. Nipro Diagnostics Basic Information, Non-Invasive Glucose Monitoring Manufacturing Base, Sales Area and Its Competitors
Table 104. Nipro Diagnostics Non-Invasive Glucose Monitoring Product Portfolios and Specifications
Table 105. Nipro Diagnostics Non-Invasive Glucose Monitoring Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 106. Nipro Diagnostics Main Business
Table 107. Nipro Diagnostics Latest Developments
Table 108. Life Scan Inc.(J&J) Basic Information, Non-Invasive Glucose Monitoring Manufacturing Base, Sales Area and Its Competitors
Table 109. Life Scan Inc.(J&J) Non-Invasive Glucose Monitoring Product Portfolios and Specifications
Table 110. Life Scan Inc.(J&J) Non-Invasive Glucose Monitoring Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 111. Life Scan Inc.(J&J) Main Business
Table 112. Life Scan Inc.(J&J) Latest Developments
Table 113. Arkray Devices Basic Information, Non-Invasive Glucose Monitoring Manufacturing Base, Sales Area and Its Competitors
Table 114. Arkray Devices Non-Invasive Glucose Monitoring Product Portfolios and Specifications
Table 115. Arkray Devices Non-Invasive Glucose Monitoring Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 116. Arkray Devices Main Business
Table 117. Arkray Devices Latest Developments
Table 118. Nova Biomedical Basic Information, Non-Invasive Glucose Monitoring Manufacturing Base, Sales Area and Its Competitors
Table 119. Nova Biomedical Non-Invasive Glucose Monitoring Product Portfolios and Specifications
Table 120. Nova Biomedical Non-Invasive Glucose Monitoring Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 121. Nova Biomedical Main Business
Table 122. Nova Biomedical Latest Developments
Table 123. Bionime Corporation Basic Information, Non-Invasive Glucose Monitoring Manufacturing Base, Sales Area and Its Competitors
Table 124. Bionime Corporation Non-Invasive Glucose Monitoring Product Portfolios and Specifications
Table 125. Bionime Corporation Non-Invasive Glucose Monitoring Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 126. Bionime Corporation Main Business
Table 127. Bionime Corporation Latest Developments
Table 128. Sinocare Basic Information, Non-Invasive Glucose Monitoring Manufacturing Base, Sales Area and Its Competitors
Table 129. Sinocare Non-Invasive Glucose Monitoring Product Portfolios and Specifications
Table 130. Sinocare Non-Invasive Glucose Monitoring Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 131. Sinocare Main Business
Table 132. Sinocare Latest Developments
Table 133. Hybio Pharmaceutical Basic Information, Non-Invasive Glucose Monitoring Manufacturing Base, Sales Area and Its Competitors
Table 134. Hybio Pharmaceutical Non-Invasive Glucose Monitoring Product Portfolios and Specifications
Table 135. Hybio Pharmaceutical Non-Invasive Glucose Monitoring Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 136. Hybio Pharmaceutical Main Business
Table 137. Hybio Pharmaceutical Latest Developments
Table 138. Lepu Medical Basic Information, Non-Invasive Glucose Monitoring Manufacturing Base, Sales Area and Its Competitors
Table 139. Lepu Medical Non-Invasive Glucose Monitoring Product Portfolios and Specifications
Table 140. Lepu Medical Non-Invasive Glucose Monitoring Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 141. Lepu Medical Main Business
Table 142. Lepu Medical Latest Developments
Table 143. Yuyue Medical Basic Information, Non-Invasive Glucose Monitoring Manufacturing Base, Sales Area and Its Competitors
Table 144. Yuyue Medical Non-Invasive Glucose Monitoring Product Portfolios and Specifications
Table 145. Yuyue Medical Non-Invasive Glucose Monitoring Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 146. Yuyue Medical Main Business
Table 147. Yuyue Medical Latest Developments

LIST OF FIGURES

Figure 1. Picture of Non-Invasive Glucose Monitoring
Figure 2. Non-Invasive Glucose Monitoring Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Non-Invasive Glucose Monitoring Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Non-Invasive Glucose Monitoring Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Non-Invasive Glucose Monitoring Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Wearable Blood Glucose Monitoring Systems
Figure 10. Product Picture of Table Top Blood Glucose Monitoring Systems
Figure 11. Global Non-Invasive Glucose Monitoring Sales Market Share by Type in 2023
Figure 12. Global Non-Invasive Glucose Monitoring Revenue Market Share by Type (2019-2024)
Figure 13. Non-Invasive Glucose Monitoring Consumed in Hospitals
Figure 14. Global Non-Invasive Glucose Monitoring Market: Hospitals (2019-2024) & (K Units)
Figure 15. Non-Invasive Glucose Monitoring Consumed in Clinics
Figure 16. Global Non-Invasive Glucose Monitoring Market: Clinics (2019-2024) & (K Units)
Figure 17. Non-Invasive Glucose Monitoring Consumed in Others
Figure 18. Global Non-Invasive Glucose Monitoring Market: Others (2019-2024) & (K Units)
Figure 19. Global Non-Invasive Glucose Monitoring Sales Market Share by Application (2023)
Figure 20. Global Non-Invasive Glucose Monitoring Revenue Market Share by Application in 2023
Figure 21. Non-Invasive Glucose Monitoring Sales Market by Company in 2023 (K Units)
Figure 22. Global Non-Invasive Glucose Monitoring Sales Market Share by Company in 2023
Figure 23. Non-Invasive Glucose Monitoring Revenue Market by Company in 2023 ($ Million)
Figure 24. Global Non-Invasive Glucose Monitoring Revenue Market Share by Company in 2023
Figure 25. Global Non-Invasive Glucose Monitoring Sales Market Share by Geographic Region (2019-2024)
Figure 26. Global Non-Invasive Glucose Monitoring Revenue Market Share by Geographic Region in 2023
Figure 27. Americas Non-Invasive Glucose Monitoring Sales 2019-2024 (K Units)
Figure 28. Americas Non-Invasive Glucose Monitoring Revenue 2019-2024 ($ Millions)
Figure 29. APAC Non-Invasive Glucose Monitoring Sales 2019-2024 (K Units)
Figure 30. APAC Non-Invasive Glucose Monitoring Revenue 2019-2024 ($ Millions)
Figure 31. Europe Non-Invasive Glucose Monitoring Sales 2019-2024 (K Units)
Figure 32. Europe Non-Invasive Glucose Monitoring Revenue 2019-2024 ($ Millions)
Figure 33. Middle East & Africa Non-Invasive Glucose Monitoring Sales 2019-2024 (K Units)
Figure 34. Middle East & Africa Non-Invasive Glucose Monitoring Revenue 2019-2024 ($ Millions)
Figure 35. Americas Non-Invasive Glucose Monitoring Sales Market Share by Country in 2023
Figure 36. Americas Non-Invasive Glucose Monitoring Revenue Market Share by Country in 2023
Figure 37. Americas Non-Invasive Glucose Monitoring Sales Market Share by Type (2019-2024)
Figure 38. Americas Non-Invasive Glucose Monitoring Sales Market Share by Application (2019-2024)
Figure 39. United States Non-Invasive Glucose Monitoring Revenue Growth 2019-2024 ($ Millions)
Figure 40. Canada Non-Invasive Glucose Monitoring Revenue Growth 2019-2024 ($ Millions)
Figure 41. Mexico Non-Invasive Glucose Monitoring Revenue Growth 2019-2024 ($ Millions)
Figure 42. Brazil Non-Invasive Glucose Monitoring Revenue Growth 2019-2024 ($ Millions)
Figure 43. APAC Non-Invasive Glucose Monitoring Sales Market Share by Region in 2023
Figure 44. APAC Non-Invasive Glucose Monitoring Revenue Market Share by Regions in 2023
Figure 45. APAC Non-Invasive Glucose Monitoring Sales Market Share by Type (2019-2024)
Figure 46. APAC Non-Invasive Glucose Monitoring Sales Market Share by Application (2019-2024)
Figure 47. China Non-Invasive Glucose Monitoring Revenue Growth 2019-2024 ($ Millions)
Figure 48. Japan Non-Invasive Glucose Monitoring Revenue Growth 2019-2024 ($ Millions)
Figure 49. South Korea Non-Invasive Glucose Monitoring Revenue Growth 2019-2024 ($ Millions)
Figure 50. Southeast Asia Non-Invasive Glucose Monitoring Revenue Growth 2019-2024 ($ Millions)
Figure 51. India Non-Invasive Glucose Monitoring Revenue Growth 2019-2024 ($ Millions)
Figure 52. Australia Non-Invasive Glucose Monitoring Revenue Growth 2019-2024 ($ Millions)
Figure 53. China Taiwan Non-Invasive Glucose Monitoring Revenue Growth 2019-2024 ($ Millions)
Figure 54. Europe Non-Invasive Glucose Monitoring Sales Market Share by Country in 2023
Figure 55. Europe Non-Invasive Glucose Monitoring Revenue Market Share by Country in 2023
Figure 56. Europe Non-Invasive Glucose Monitoring Sales Market Share by Type (2019-2024)
Figure 57. Europe Non-Invasive Glucose Monitoring Sales Market Share by Application (2019-2024)
Figure 58. Germany Non-Invasive Glucose Monitoring Revenue Growth 2019-2024 ($ Millions)
Figure 59. France Non-Invasive Glucose Monitoring Revenue Growth 2019-2024 ($ Millions)
Figure 60. UK Non-Invasive Glucose Monitoring Revenue Growth 2019-2024 ($ Millions)
Figure 61. Italy Non-Invasive Glucose Monitoring Revenue Growth 2019-2024 ($ Millions)
Figure 62. Russia Non-Invasive Glucose Monitoring Revenue Growth 2019-2024 ($ Millions)
Figure 63. Middle East & Africa Non-Invasive Glucose Monitoring Sales Market Share by Country in 2023
Figure 64. Middle East & Africa Non-Invasive Glucose Monitoring Revenue Market Share by Country in 2023
Figure 65. Middle East & Africa Non-Invasive Glucose Monitoring Sales Market Share by Type (2019-2024)
Figure 66. Middle East & Africa Non-Invasive Glucose Monitoring Sales Market Share by Application (2019-2024)
Figure 67. Egypt Non-Invasive Glucose Monitoring Revenue Growth 2019-2024 ($ Millions)
Figure 68. South Africa Non-Invasive Glucose Monitoring Revenue Growth 2019-2024 ($ Millions)
Figure 69. Israel Non-Invasive Glucose Monitoring Revenue Growth 2019-2024 ($ Millions)
Figure 70. Turkey Non-Invasive Glucose Monitoring Revenue Growth 2019-2024 ($ Millions)
Figure 71. GCC Country Non-Invasive Glucose Monitoring Revenue Growth 2019-2024 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Non-Invasive Glucose Monitoring in 2023
Figure 73. Manufacturing Process Analysis of Non-Invasive Glucose Monitoring
Figure 74. Industry Chain Structure of Non-Invasive Glucose Monitoring
Figure 75. Channels of Distribution
Figure 76. Global Non-Invasive Glucose Monitoring Sales Market Forecast by Region (2025-2030)
Figure 77. Global Non-Invasive Glucose Monitoring Revenue Market Share Forecast by Region (2025-2030)
Figure 78. Global Non-Invasive Glucose Monitoring Sales Market Share Forecast by Type (2025-2030)
Figure 79. Global Non-Invasive Glucose Monitoring Revenue Market Share Forecast by Type (2025-2030)
Figure 80. Global Non-Invasive Glucose Monitoring Sales Market Share Forecast by Application (2025-2030)
Figure 81. Global Non-Invasive Glucose Monitoring Revenue Market Share Forecast by Application (2025-2030)


More Publications